AgeX Therapeutics Inc
AGE
Market Cap$27.76M
Close$
$-3.97
135.8% downside
Current Fair Value
135.8% downsideOvervalued by 135.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $27.76 Million |
|---|---|
| Enterprise Value | $31.78 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-14.0 |
| Beta | -0.9 |
| Outstanding Shares | 2,500,664 |
| Avg 30 Day Volume | 9,027 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.88 |
|---|---|
| PEG | -6.73 |
| Price to Sales | - |
| Price to Book Ratio | 5.55 |
| Enterprise Value to Revenue | 223.78 |
| Enterprise Value to EBIT | -3.19 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
ESG Score
No data
About AgeX Therapeutics Inc
CEO: Michael West